The NLRP3–ASC inflammasome, which is explored for therapeutic strategies for a variety of diseases hence presents as an interesting therapeutic approach targeting key pathogenetic processes in AD, including Tau pathology besides Aβ and neuroinflammation. The gene discussed is NLRP3; the disease is Alzheimer disease.